BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 10:03:00 AM | Browse: 1293 | Download: 1469
 |
Received |
|
2013-12-12 16:56 |
|
Peer-Review Started |
|
2013-12-13 08:17 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-01-17 13:16 |
|
Revised |
|
2014-01-30 04:26 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-05-08 17:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-05-08 17:53 |
|
Articles in Press |
|
2014-05-23 09:15 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-06-13 21:03 |
|
Publish the Manuscript Online |
|
2014-06-16 15:44 |
| Category |
Engineering, Biomedical |
| Manuscript Type |
Topic Highlights |
| Article Title |
Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hyun Joon Paek, Courtney Kim and Stuart K Williams |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hyun Joon Paek, PhD, Director, Biologics, Tissue Genesis Institute, LLC, 810 Richards Street, Suite 1000, Honolulu, HI 96813, United States. jpaek@tissuegenesis.com |
| Key Words |
Diabetes mellitus; Diabetes; Insulin; Stem cells; Adipose; Pancreas; Beta-cells; Differentiation |
| Core Tip |
Adipose-derived stem cells (ADSCs) can provide a promising cell therapy for treatment of diabetes and associated complications. ADSCs’ multipotency allows differentiation into insulin-producing ?-cells. Anti-inflammatory and immunomodulatory capabilities of ADSCs can facilitate enhanced engraftment of transplanted donor islets. Although many challenges lie ahead for ADSC-based cell therapies are used clinically to treat diabetic hyperglycemia, ADSCs represent a novel treatment option to many diabetic patients worldwide. |
| Publish Date |
2014-06-16 15:44 |
| Citation |
Paek HJ, Kim C, Williams SK. Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia. World J Diabetes 2014; 5(3): 235-243
|
| URL |
http://www.wjgnet.com/1948-9358/full/v5/i3/235.htm |
| DOI |
http://dx.doi.org/10.4239/wjd.v5.i3.235 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
